# Phase 8A Shadow Trading Closure

Version: 1.0.0

Date: 2026-07-17

Architecture Baseline: ABR-1.0

Status: Complete — operational and safety PASS; deployment denied

## Closure decision

Phase 8A delivered the complete non-broker canonical workflow:

`Market -> Brain -> AI Runtime -> Decision -> Risk -> Shadow Execution -> Paper Trade Lifecycle`

Stages 8A.1 through 8A.5 pass. Stage 8A.6 completed its evidence and comparison
work with a formal model-quality NO-GO. A NO-GO is the correct closed outcome
when the approved quality gates are not met; it does not make the operational
Shadow platform incomplete.

## Delivered controls

- safe-default Shadow mode and hard live lock;
- explicit Decision-to-Risk-to-Execution approval chain;
- synthetic paper positions with SL, TP, holding time, spread, and slippage;
- duplicate-bar, stale-bar, active-exposure, daily-loss, drawdown, and
  emergency-stop protection;
- persistent Forward state and isolated Strategy Tester state;
- heartbeat, Decision, Audit, State, Telemetry, and final Report evidence;
- broker-closure audit with no mutation path;
- Feature Schema 4.0 twelve-dimensional canonical evidence;
- explicit inference-provider boundary and post-Shutdown identity retention;
- Strategy Tester-only experimental-provider lock;
- independent cross-file artifact validation.

## Accepted evidence

Legacy full-period V4:

- 1,895 Decisions over 21 market days;
- SELL / WAIT / BUY: 1,128 / 767 / 0;
- Profit Factor 0.7680; expectancy -83.9444 points;
- broker state unchanged and evidence valid.

Directional research comparison:

- 1,895 Decisions over the same period;
- SELL / HOLD / BUY: 1,118 / 272 / 505;
- Profit Factor 0.3328; expectancy -286.4286 points;
- broker state unchanged and evidence valid;
- Forward promotion rejected.

Focused and automated validation:

- canonical no-broker include closure: 106 files;
- broker-capable files / mutation tokens: 0 / 0;
- Python regression: 32/32;
- focused Brain, Risk, Execution, backtest, freshness, provider, Forward-lock,
  mapping, and report-identity contracts passed;
- synchronized MetaEditor compile runner requires zero errors and zero
  warnings for every target.

## Deployment state

- active Forward provider: `DEVELOPMENT_HEURISTIC_4_SCALAR_NO_GO`
- Directional research provider: rejected for Forward
- model deployment authorized: false
- live execution authorized: false
- broker orders authorized: false

## Next phase boundary

Future model research must begin under a new approved change request. It must
not weaken Risk limits, reuse inspected periods as untouched evidence, or
silently promote either Phase 8A provider. A future candidate requires fresh
temporal data, stable walk-forward results, an untouched final test, and
explicit owner approval before Forward Shadow model deployment.

